Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results

Authors: ...
 9th Sep 2023  PubMed
Posted by Alumni
June 6, 2025

Humans

Male

Positron Emission Tomography Computed Tomography* / methods

Prostate / pathology

Prostate-Specific Antigen

Prostatic Neoplasms* / diagnostic imaging

Prostatic Neoplasms* / pathology

Prostatic Neoplasms* / therapy

gallium 68 PSMA-11

Background: Treatment response is traditionally monitored using prostate-specific antigen (PSA) and conventional imaging in patients with metastatic prostate cancer (mPCa). learn more on PubMed
AUTHORS